Skip to main content
Caplight Logo









BioMe Inc.

BioMe Inc.

Private
SeoulHealthcare & Life Scienceshttps://bio-me.co.kr/

Last Round

Series A

Dec 3, 2024

Total Funding Raised

$2.11M

Company Overview

BioMe Inc. is a biotechnology company that develops microbiome-based live biotherapeutic products (LBPs) for the treatment of chronic and intractable diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

microbiomelive biotherapeutic productsLBPmicrobiome therapeuticsprecision medicinegut healthmicrobiome analysisbiotechnology R&Ddrug developmentclinical researchprobiotic researchbioinformaticsgut microbiome testingpersonalized healthbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioMe Inc. Comparables

Compare BioMe Inc. with similar companies based on industry and business-model similarity.

BioMe Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CJ Bioscience Inc.
76%
HEM Pharma Inc.
73%
Tiny Health
71%

BioMe Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 3, 2024
Pre SeedOct 5, 2021

BioMe Inc. Investors

Notable investors and investment history

BioMe Inc. investors
InvestorRounds
ScaleUp PartnersSeries A, Pre Seed
CelltrionSeries A
Mirae Asset Venture InvestmentPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2024

    $2.1M round led by Celltrion

  • Oct 5, 2021

    Mirae Asset Venture Investment led the round.

BioMe Inc. Filings

Explore SEC and related filing metadata, where available.

BioMe Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioMe Inc.'s valuation, stock price, and market status.

Is BioMe Inc. a public or private company?

BioMe Inc. is a private company.

What is the current stock price of BioMe Inc.?

BioMe Inc. is a private company with no public stock price. Caplight tracks BioMe Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is BioMe Inc. worth (valuation)?

Valuation information for BioMe Inc. is not publicly available.

Can I buy BioMe Inc. stock?

BioMe Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioMe Inc.'s last funding round?

BioMe Inc.'s most recent funding round was Series A on December 3, 2024.

Who are the main investors in BioMe Inc.?

Key investors in BioMe Inc. include Celltrion, Mirae Asset Venture Investment.

Will BioMe Inc. IPO soon?

No public IPO plans have been announced for BioMe Inc..

How can I track BioMe Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioMe Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range1
Year Founded2020
Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?